Interaction of Volatile Anesthetics With Magnesium - Trial NCT05261516
Access comprehensive clinical trial information for NCT05261516 through Pure Global AI's free database. This Phase 4 trial is sponsored by Christoph Czarnetzki and is currently Not yet recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 96 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Christoph Czarnetzki
University Hospital, Geneva
Timeline & Enrollment
Phase 4
Mar 15, 2022
Mar 15, 2024
Primary Outcome
Change in TOF ratio after perfusion of magnesium
Summary
Magnesium and volatiles anesthetics both have an effect on the neuromuscular transmission.
 The primary objective of the study is to quantify the effect of a perfusion of intravenous
 magnesium on neuromuscular transmission measured by acceleromyography with the TofScan device
 in patients undergoing general anesthesia with volatile anesthetics (desflurane, sevoflurane
 and isoflurane) as compared to intravenous anesthesia with propofol.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05261516
Non-Device Trial

